Stonebridge Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200
Closed -$17.4K 306
2023
Q3
$17.4K Sell
200
-106
-35% -$9.58K ﹤0.01% 524
2023
Q2
$28.9K Buy
+306
New +$25.8K ﹤0.01% 445
2021
Q3
Sell
-33
Closed -$2K 971
2021
Q2
$2K Hold
33
﹤0.01% 922
2021
Q1
$2K Buy
+33
New +$1.82K ﹤0.01% 823

Other funds holding CAH

Stonebridge Capital Advisors's CAH Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 200 shares — an estimated $17.4K sold.

Stonebridge Capital Advisors first reported a position in CAH in Q1 2021 and held it in 4 quarters. The position peaked at $28.9K in Q2 2023. 1,037 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 200 Cardinal Health shares in Q4 2023, an estimated $17.4K.
  • Stonebridge Capital Advisors first reported a position in Cardinal Health in Q1 2021 and held it in 4 quarters.
  • Stonebridge Capital Advisors's Cardinal Health position peaked at $28.9K in Q2 2023.
  • 1,037 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.